Polypill strategy for secondary cardiovascular prevention
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00108-023-01507-z.pdf
Reference6 articles.
1. Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G et al (2021) EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study. Eur J Prev Cardiol 28:1279–1289
2. Koenig W, Lorenz W, Beier L, Gouni-Bertholdt I (2021) Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany. Clin Res Cardiol. https://doi.org/10.1007/s00392-021-01933-9
3. Brandts J, Ray KK (2020) Low density lipoprotein cholesterol-lowering strategies and population health: time to move to a cumulative exposure model. Circulation 141:873–876
4. Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A et al (2022) SECURE Investigators. Polypill strategy in secondary cardiovascular prevention. N Engl J Med 387:967–977
5. Simpson WG (2019) Biomarker variability and cardiovascular disease residual risk. Curr Opin Cardiol 34:413–417
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3